|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Real estate | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Short-term investments | ||||||||||||||||||||
| Notes receivable (including $64,835 and $67,349 at June 30, 2026 and December 31, 2025, respectively, from related parties) | ||||||||||||||||||||
| Investment in unconsolidated joint ventures | ||||||||||||||||||||
| Receivable from related party | ||||||||||||||||||||
| Other assets (including $1,214 and $1,475 at June 30, 2026 and December 31, 2025, respectively, from related parties) | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities and Equity | ||||||||||||||||||||
| Liabilities: | ||||||||||||||||||||
| Mortgages and other notes payable | ||||||||||||||||||||
| Bonds payable | ||||||||||||||||||||
| Accounts payable and other liabilities (including $31 and $30 at June 30, 2026 and December 31, 2025, respectively, from related parties) | ||||||||||||||||||||
| Accrued interest | ||||||||||||||||||||
| Deferred revenue | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Shareholders' Equity: | ||||||||||||||||||||
| Preferred stock, Series A, $2.00 par value, 15,000,000 shares authorized, 900,614 shares issued and outstanding | ||||||||||||||||||||
| Common stock, $0.01 par value, 100,000,000 shares authorized; 16,152,043 shares issued and outstanding | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Total shareholders' equity | ||||||||||||||||||||
| Noncontrolling interests | ||||||||||||||||||||
| Total equity | ||||||||||||||||||||
| Total liabilities and equity | ||||||||||||||||||||
Loading...
